Patent · US Active

Combination therapy for treating or preventing an inflammatory skin disorder

US9186358B2 · kind B2 · utility

3Cited by

59References

2Claims

0Family size

Assignee

Galderma Laboratories, L.P. · US

Inventors

Andre Jomard · Grasse, FR
Françoise Delamadeleine · Antibes, FR

Key dates

Filing date	Nov 18, 2010
Grant date	Nov 17, 2015
Priority date	—
Expiry date	Nov 18, 2030

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P29/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Methods and compositions for improved treatment and prevention of an inflammatory skin disorder or a sign and/or symptom associated with the skin disorder are described. The methods involve topical application to the skin a combination of a therapeutically effective amount of an α2 adrenergic receptor agonist, such as brimonidine, and a therapeutically effective amount of a non-steroidal anti-inflammatory agent, such as diclofenac.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.